ClinicalTrials.Veeva

Menu

Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny (CCOMET)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Conotruncal Cardiac Defects

Treatments

Biological: Bood sampling for biochemicals and genetic analysis

Study type

Observational

Funder types

Other

Identifiers

NCT01460316
2011-A00346-35

Details and patient eligibility

About

The investigators planned to study the etiopathogenic factors of conotruncal cardiac defects regarding the relations between the metabolic, the genetic and the environmental factors which lead to these cardiopathy.

Enrollment

400 patients

Sex

All

Ages

1+ month old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Conotruncal cardiac defects patients and theirs mothers
  • Weight: > 3750 g

Exclusion criteria

  • Syndromic conotruncal cardiac defects
  • 22q11 deletion Holder's
  • Patients whose mother's took anti-folates before and during first pregnancy semester

Trial design

400 participants in 2 patient groups

Conotruncal cardiac defects patients
Treatment:
Biological: Bood sampling for biochemicals and genetic analysis
Mothers of patients
Treatment:
Biological: Bood sampling for biochemicals and genetic analysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems